{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T17:48:22Z","timestamp":1789321702801,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T00:00:00Z","timestamp":1560816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.vaccine.2019.06.043","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T10:02:33Z","timestamp":1562234553000},"page":"4533-4542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice"],"prefix":"10.1016","volume":"37","author":[{"given":"Michael J.","family":"Moser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Hatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Gabaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Sarawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Hatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamuk","family":"Bilsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.06.043_b0005","unstructured":"CDC About Flu; 2018; Available from: https:\/\/www.cdc.gov\/flu\/about\/index.html [cited 2018 June 19]."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.06.043_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/irv.12319","article-title":"Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study","volume":"9","author":"Caini","year":"2015","journal-title":"Influenza Other Respir Viruses"},{"issue":"3","key":"10.1016\/j.vaccine.2019.06.043_b0015","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.2105\/AJPH.2012.301137","article-title":"The burden of influenza B: a structured literature review","volume":"103","author":"Paul Glezen","year":"2013","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.043_b0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0042-6822(90)90186-U","article-title":"Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983","volume":"175","author":"Rota","year":"1990","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.043_b0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4161\/hv.8.1.17623","article-title":"The rationale for quadrivalent influenza vaccines","volume":"8","author":"Ambrose","year":"2012","journal-title":"Hum Vacc Immunother"},{"issue":"9","key":"10.1016\/j.vaccine.2019.06.043_b0030","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.vaccine.2009.11.068","article-title":"Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity","volume":"28","author":"Belshe","year":"2010","journal-title":"Vaccine"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2019.06.043_b0035","doi-asserted-by":"crossref","first-page":"D45","DOI":"10.1016\/j.vaccine.2010.08.028","article-title":"The need for quadrivalent vaccine against seasonal influenza","volume":"28","author":"Belshe","year":"2010","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2019.06.043_b0040","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/cid\/ciu664","article-title":"Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999\u20132012","volume":"59","author":"Heikkinen","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.043_b0045","first-page":"E28","article-title":"Quadrivalent influenza vaccine: a new opportunity to reduce the influenza burden","volume":"57","author":"Tisa","year":"2016","journal-title":"J Prev Med Hyg"},{"key":"10.1016\/j.vaccine.2019.06.043_b0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1471-2334-13-224","article-title":"Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults","volume":"13","author":"Beran","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"40","key":"10.1016\/j.vaccine.2019.06.043_b0055","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1016\/j.vaccine.2018.04.043","article-title":"A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses","volume":"36","author":"van de Witte","year":"2018","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2019.06.043_b0060","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1586\/erv.12.108","article-title":"Quadrivalent Ann Arbor strain live-attenuated influenza vaccine","volume":"11","author":"Toback","year":"2012","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2019.06.043_b0065","unstructured":"CDC. Available from: https:\/\/www.cdc.gov\/flu\/professionals\/vaccination\/effectiveness-studies.htm."},{"issue":"5","key":"10.1016\/j.vaccine.2019.06.043_b0070","doi-asserted-by":"crossref","DOI":"10.2807\/ese.18.05.20390-en","article-title":"Low and decreasing vaccine effectiveness against influenza A(H3) in 2011\/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study","volume":"18","author":"Kissling","year":"2013","journal-title":"Euro Surveill"},{"issue":"5","key":"10.1016\/j.vaccine.2019.06.043_b0075","doi-asserted-by":"crossref","DOI":"10.2807\/ese.18.05.20389-en","article-title":"Vaccine effectiveness of 2011\/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection","volume":"18","author":"Pebody","year":"2013","journal-title":"Euro Surveill"},{"issue":"5","key":"10.1016\/j.vaccine.2019.06.043_b0080","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/infdis\/jix632","article-title":"Duration of influenza vaccine effectiveness: a systematic review, meta-analysis, and meta-regression of test-negative design case-control studies","volume":"217","author":"Young","year":"2018","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.06.043_b0085","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/cid\/ciw816","article-title":"Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011\u201312 through 2014\u201315","volume":"64","author":"Ferdinands","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"42","key":"10.1016\/j.vaccine.2019.06.043_b0090","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1016\/j.vaccine.2016.08.061","article-title":"M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice","volume":"34","author":"Sarawar","year":"2016","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2019.06.043_b0095","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1016\/j.vaccine.2017.06.039","article-title":"M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza","volume":"35","author":"Hatta","year":"2017","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2019.06.043_b0100","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1128\/JVI.78.11.5576-5583.2004","article-title":"Influenza B virus requires BM2 protein for replication","volume":"78","author":"Hatta","year":"2004","journal-title":"J Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2019.06.043_b0105","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"10.1016\/j.vaccine.2019.06.043_b0110","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.1073\/pnas.172393399","article-title":"Rescue of influenza B virus from eight plasmids","volume":"99","author":"Hoffmann","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2019.06.043_b0115","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1128\/JVI.00450-09","article-title":"Influenza A virus lacking M2 protein as a live attenuated vaccine","volume":"83","author":"Watanabe","year":"2009","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2019.06.043_b0120","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.vaccine.2011.01.023","article-title":"An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus","volume":"29","author":"Hatta","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.043_b0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1741-7015-11-153","article-title":"Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis","volume":"11","author":"Tricco","year":"2013","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.vaccine.2019.06.043_b0130","doi-asserted-by":"crossref","first-page":"e38929","DOI":"10.1371\/journal.pone.0038929","article-title":"Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B\/Yamagata dominance","volume":"7","author":"Skowronski","year":"2012","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.vaccine.2019.06.043_b0135","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/INF.0b013e31822db4dc","article-title":"Influenza B\/Victoria antigen induces strong recall of B\/Yamagata but lower Beta\/Victoria response in children primed with two doses of Beta\/Yamagata","volume":"30","author":"Skowronski","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"35","key":"10.1016\/j.vaccine.2019.06.043_b0140","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1016\/j.vaccine.2016.06.064","article-title":"Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: a systematic review and meta-analysis of randomised controlled trials","volume":"34","author":"Moa","year":"2016","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.06.043_b0145","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.5.18-00035","article-title":"Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017\/18 vaccine effectiveness, Canada, January 2018","volume":"23","author":"Skowronski","year":"2018","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.vaccine.2019.06.043_b0150","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/infdis\/jix509","article-title":"Evidence for viral interference and cross-reactive protective immunity between influenza B virus lineages","volume":"217","author":"Laurie","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.043_b0155","doi-asserted-by":"crossref","first-page":"9695628","DOI":"10.1155\/2018\/9695628","article-title":"Cross-protective efficacy of monovalent live influenza B vaccines against genetically different lineages of B\/Victoria and B\/Yamagata in ferrets","volume":"2018","author":"Kiseleva","year":"2018","journal-title":"Biomed Res Int"},{"issue":"8","key":"10.1016\/j.vaccine.2019.06.043_b0160","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1099\/vir.0.000156","article-title":"Influenza B virus-specific CD8+ T-lymphocytes strongly cross-react with viruses of the opposing influenza B lineage","volume":"96","author":"van de Sandt","year":"2015","journal-title":"J Gen Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2019.06.043_b0165","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr Opin Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2019.06.043_b0170","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00286-17","article-title":"Chimeric hemagglutinin constructs induce broad protection against influenza B virus challenge in the mouse model","volume":"91","author":"Ermler","year":"2017","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2019.06.043_b0175","article-title":"Native human monoclonal antibodies with potent cross-lineage neutralization of influenza B viruses","volume":"62","author":"Vigil","year":"2018","journal-title":"Antimicrob Age Chemother"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.043_b0180","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41467-018-08165-y","article-title":"Cross-lineage protection by human antibodies binding the influenza B hemagglutinin","volume":"10","author":"Liu","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2019.06.043_b0185","article-title":"Broadly cross-reactive, non-neutralizing antibodies against the influenza B virus hemagglutinin demonstrate effector function dependent protection against lethal viral challenge in mice","author":"Arunkumar","year":"2019","journal-title":"J Virol"},{"issue":"6100","key":"10.1016\/j.vaccine.2019.06.043_b0190","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.043_b0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/infdis\/jix546","article-title":"Primary human influenza B virus infection induces cross-lineage hemagglutinin stalk-specific antibodies mediating antibody-dependent cellular cytoxicity","volume":"217","author":"de Vries","year":"2017","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.06.043_b0200","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbrc.2018.05.148","article-title":"Identification of immunodominant CD8 epitope in the stalk domain of influenza B viral hemagglutinin","volume":"502","author":"Muralidharan","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.vaccine.2019.06.043_b0205","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1164\/rccm.200511-1751OC","article-title":"Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice","volume":"174","author":"Xu","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.vaccine.2019.06.043_b0210","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"12","key":"10.1016\/j.vaccine.2019.06.043_b0215","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist(R); Fluenz): a review of its use in the prevention of seasonal influenza in children and adults","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.043_b0220","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4161\/hv.8.1.18809","article-title":"Live attenuated intranasal influenza vaccine","volume":"8","author":"Esposito","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"31","key":"10.1016\/j.vaccine.2019.06.043_b0225","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.vaccine.2011.04.113","article-title":"A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years","volume":"29","author":"Tennis","year":"2011","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19308059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19308059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:44Z","timestamp":1759401224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19308059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":45,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0264410X19308059"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}